Ad is loading...

CSBR Champions Oncology Forecast, Technical & Fundamental Analysis

a provider of advanced technology solutions and services for oncology drugs

Industry Biotechnology

Get AI intraday signals

View a ticker or compare two or three

Compare

Ad is loading...

A.I. Advisor

published Earnings

CSBR is expected to report earnings to fall 127.27% to -2 cents per share on December 16

Champions Oncology CSBR Stock Earnings Reports

Q4'24

Est.

$-0.03

Q3'24

Beat

by $0.14

Q2'24

Beat

by $0.17

Q1'24

Missed

by $0.10

Q4'23

Beat

by $0.01

The last earnings report on September 11 showed earnings per share of 10 cents, beating the estimate of -2 cents. With 4.95K shares outstanding, the current market capitalization sits at 61.17M.

A.I. Advisor

published General Information

General Information

a provider of advanced technology solutions and services for oncology drugs

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

One University Plaza

Phone

+1 201 808-8400

Employees

230

Web

https://www.championsoncology.com

Interesting Tickers

MFs / NAME	Price $	Chg $	Chg %
		1 Day
FAPLX	13.24	-0.13	-0.97%
Fidelity Advisor Healthy Future M
LKEQX	40.66	-0.49	-1.19%
LKCM Equity
MXKWX	9.63	-0.13	-1.33%
Empower S&P 500® Index Institutional
MUEUX	39.47	-0.62	-1.55%
MFS Blended Research Core Equity R4
TMCAX	12.90	-0.27	-2.05%
RBC SMID Cap Growth A

CSBR and Stocks

Correlation & Price change

A.I.dvisor tells us that CSBR and SYRE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSBR and SYRE's prices will move in lockstep.

Ticker / NAME	Correlation To CSBR	1D Price Change %
CSBR	100%	+0.90%
SYRE - CSBR	32% Poorly correlated	-6.62%
SCNI - CSBR	27% Poorly correlated	-4.36%
OABI - CSBR	25% Poorly correlated	-4.67%
PLUR - CSBR	24% Poorly correlated	-1.28%
MNOV - CSBR	24% Poorly correlated	+0.27%
More